abagovomab 27
abciximab 21
abituzumab 12
abrilumab 12
actoxumab 11
adalimumab 9
aducanumab 9
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 27
alirocumab 14
amatuximab 20
andecaliximab 17
anifrolumab 15
anrukinzumab 13
aprutumab 10
aprutumab_ixadotin 10
arcitumomab 13
ascrinvacumab 0
atezolizumab 10
atinumab 11
avelumab 7
basiliximab 20
bavituximab 17
begelomab 14
benralizumab 19
bevacizumab_beta 16
bezlotoxumab 11
bimagrumab 9
bleselumab 14
blinatumomab 24
blosozumab 25
bococizumab 18
brazikumab 13
brentuximab_vedotin 18
briakinumab 13
brodalumab 7
brolucizumab 16
brontictuzumab 22
burosumab 17
cabiralizumab 19
camrelizumab 14
canakinumab 18
cantuzumab_ravtansin 26
carlumab 12
carotuximab 8
cergutuzumab_amunaleukin2 25
cergutuzumab_amunaleukin 25
certolizumab_pegol 22
cetiximab 27
citatuzumab_bogatox 24
cixutumumab 16
clivatuzumab_tetraxetan 11
codrituzumab 19
conatumumab 10
concizumab 14
crenezumab 14
crizanlizumab 17
crotedumab 17
dacetuzumab 21
daclizumab 9
dalotuzumab 18
dapirolizumab_pegol 25
daratumumab 11
dectrekumab 7
demcizumab 20
denosumab 7
depatuxizumab 14
depatuxizumab_mafodotin 14
dezamizumab 14
dinutuximab 23
diridavumab 11
domagrozumab 11
drozitumab 12
duligotuzumab 20
durvalumab 12
dusigitumab 20
efalizumab 33
efungumab 17
eldelumab 15
elezanumab 15
elgemtumab 4
elotuzumab 13
emactuzumab 12
emapalumab 14
emibetuzumab 16
enavatuzumab 23
enfortumab_vedotin 9
enoblituzumab 17
enokizumab 20
enoticumab 16
ensituximab 21
eptinezumab 9
erenumab 16
etaracizumab 12
etrolizumab 19
evinacumab 16
evolocumab 11
farletuzumab 0
fasinumab 14
fezakinumab 14
fibatuzumab 6
ficlatuzumab 24
firivumab 22
flanvotumab 14
fletikumab 24
foralumab 9
foravirumab 13
fremanezumab 24
fresolimumab 10
fulranumab 15
futuximab 10
galcanezumab 10
ganitumab 15
gantenerumab 13
gemetuzumab 25
gemtuzumab2 23
gemtuzumab 12
gevokizumab 15
girentuximab 22
glembatumumab 15
glembatumumab_vedotin 15
guselkumab 14
ibalizumab 21
ibritumomab 16
icrucumab 13
idarucizumab 21
ifabotuzumab 6
imalumab 11
imgatuzumab 18
inclacumab 14
indatuximab_ravtansin 23
indusatumab 13
inebilizumab 16
intetumumab 7
iodine_girentuximab 20
ipilimumab 4
iratumumab 11
isatuximab 19
itolizumab 17
ixekizumab 20
labetuzumab_govitecan 22
lambrolizumab 18
lampalizumab 23
lanadelumab 16
landogrozumab 12
laprituximab 23
lebrikizumab 23
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 15
ligelizumab 13
lilotomab 24
lirilumab 18
lodelcizumab 13
lokivetmab 11
lorvotuzumab_mertansin 14
lucatumumab 22
lumretuzumab 13
lupartumab 13
lutikizumab 12
margetuximab 26
milatuzumab 18
mirvetuximab 27
mirvetuximab_soravtansin 27
modotuximab 28
mogamulizumab 17
monalizumab 18
motavizumab 27
moxetumomab_pasudotox 14
namilumab 18
naratuximab 25
naratuximab_emtansin 25
narnatumab 14
navicixizumab2 26
navicixizumab 20
navivumab 11
necitumumab 7
nemolizumab 22
nesvacumab 14
nivolumab 10
obiltoxaximab 15
obinutuzumab 24
ocaratuzumab 14
ofatumumab 12
olaratumab 9
olokizumab 19
omalizumab 16
onartuzumab 22
ontuxizumab 15
opicinumab 13
orticumab 6
otelixizumab 22
oxelumab 8
ozanezumab 17
pamrevlumab 7
panobacumab 18
parsatuzumab 27
pasotuxizumab 16
pateclizumab 15
patritumab 15
pembrolizumab 18
perakizumab 16
pidilizumab 13
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 22
polatuzumab_vedotin 17
ponezumab 21
prezalumab 14
pritoxaximab 23
quilizumab 15
racotumomab 22
radretumab 10
ralpancizumab 23
ramucirumab 8
ranevetmab 29
ranibizumab 13
refanezumab 17
remtolumab 10
rilotumumab 11
rinucumab 4
risankizumab 27
rituximab 9
rivabazumab 21
robatumumab 18
roledumab 17
romosozumab 17
rontalizumab 22
rosmantuzumab 13
rozanolixizumab 18
sacituzumab 25
sacituzumab_govitecan 25
samalizumab 21
sapelizumab 18
sarilumab 9
secukinumab 14
seribantumab 13
setoxaximab 29
sifalimumab 7
siltuximab 7
simtuzumab 24
sirukumab 8
solanezumab 22
solitomab 18
stamulumab 12
suptavumab 19
suvizumab 13
tabalumab 7
tadocizumab 11
tamtuvetmab 26
tanezumab 19
tarextumab 8
tavolixizumab 8
telisotuzumab 24
teplizumab 15
tesidolumab 17
tezepelumab 22
tigatuzumab 13
tildrakizumab 16
timolumab 10
tisotumab 9
tosatoxumab 20
tositumomab 13
tralokinumab 20
trastuzumab 24
tregalizumab 18
trevogrumab 8
ublituximab 12
urelumab 13
ustekinumab 22
utomilumab 16
vadastuximab 15
vadastuximab_talirin 15
vandortuzumab_vedotin 17
vantictumab 16
vanucizumab2 16
vanucizumab 17
varlilumab 17
vatelizumab 11
vedolizumab 10
veltuzumab 7
vesencumab 7
vorsetuzumab 21
vorsetuzumab_mafodotin 21
vunakizumab 24
xentuzumab 17
zatuximab 28
